Private Equity Belgium: Top Firms in 2026

Key Facts: Belgian PE Market at a Glance

• Private equity and venture capital firms have invested €25.7 billion in Belgian companies since 2007, according to industry body Private Capital Belgium.
• At least 17 firms operate with verified deal histories; broader counts including family offices and semi-public vehicles reach 30 or more active fund managers.
• PE and VC-backed firms employed 237,000 people across Belgium as of 2021, spanning 1,165 portfolio companies.
• Fund sizes range from €125 million at Vectis Private Equity to €14 billion in net asset value at Groupe Bruxelles Lambert, reflecting deep segmentation between SME-focused and large-cap investors.
• Brussels and Antwerp jointly host the majority of Belgium's active buyout firms and growth equity investors.
• ESG and sustainability criteria now shape deal sourcing and portfolio strategy across most Belgian PE firms, reflecting EU regulatory requirements and growing LP demand.
• The market remains resilient despite modest headwinds from economic uncertainty and rising interest rates, with growing capital flows toward cleantech, healthcare, and digital services.

Private Equity Belgium: Market Overview

Private equity in Belgium covers professional investment in unlisted companies, ranging from early-stage growth businesses to established mid-market SMEs. Investors take either majority or minority stakes in exchange for capital, with the explicit goal of accelerating growth through active ownership. The Belgian PE universe encompasses buyout firms, growth equity investors, mezzanine providers, and bank-affiliated PE arms, alongside pan-European funds that treat Belgium as a core deployment market.

Brussels and Antwerp anchor the market geographically. Brussels hosts the largest concentration of PE firms by count, including Cobepa, Groupe Bruxelles Lambert, NXMH, Core Equity Holdings, and BNP Paribas Fortis Private Equity. Antwerp is home to GIMV, Finco, and Down 2 Earth Capital, while the broader Flemish region adds Sofindev in Diegem, Integra in Ghent, and Vectis in Aalter. Wallonia is served primarily by SRIW, the regional public investment body, and PMV operates as the Flemish equivalent. This geographic split reflects Belgium's linguistic and economic divide but does not limit deal activity, as most firms invest nationally and across Benelux.

Belgium's position at the heart of European institutions in Brussels creates structural advantages for PE activity. EU regulatory frameworks, including AIFMD and mandatory ESG disclosure requirements, shape fund structures and investment mandates across the Belgian market. International firms including Blackstone, KKR, The Carlyle Group, General Atlantic, and Warburg Pincus deploy capital into Belgian targets. They compete alongside domestic fund managers for the country's stock of profitable, family-owned SMEs.

Firm Comparison at a Glance

The Belgian PE landscape spans a wide range of assets under management and strategies, from long-term holding companies managing billions to specialist SME funds under €200 million. The table below covers the most active firms with verified data.

GBL's €14 billion NAV places it well above domestic peers by scale, though its mandate blends listed equities with private assets. Strictly PE-focused, Cobepa at €4.4 billion and GIMV at €2.3 billion represent the strongest purely private equity franchises in the country.

Top Picks by Investment Strategy

Largest AUM: GBL (Groupe Bruxelles Lambert) manages €14 billion in net asset value, deploying capital across listed positions in adidas, Pernod Ricard, and SGS alongside private equity holdings including Affidea and Canyon. Its scale is unmatched domestically.

Growth Equity Leader: GIMV operates five dedicated sector platforms (Consumer, Healthcare, Life Sciences, Smart Industries, and Sustainable Cities), each with its own investment thesis and origination network. This structure gives GIMV sector depth that generalist Belgian peers cannot match.

Patient Capital Specialist: Cobepa has completed 93 transactions since 2004 without operating a fixed-term fund, allowing portfolio companies to pursue long-term strategies free from typical 5–7 year exit pressure. The firm currently manages €4.4 billion across 20 portfolio companies.

Top SME Investor: Sofindev focuses on Belgian and Benelux SMEs across diverse industries, successfully concluding its Sofindev IV fund in 2024. Portfolio companies include Altenova, Delta Engineering, Dynamate, and Euphoria Mobility.

Fintech and Financial Services Specialist: Finco is the only Belgian PE firm that invests exclusively in banking, insurance, asset management, and fintech businesses. With $180 million under management, it occupies a niche with no direct domestic competitor.

Strongest Mid-Market Platform: Core Equity Holdings holds €2 billion in gross assets and specialises in building European platform companies over a long investment horizon, applying a model closer to permanent capital than traditional closed-end buyout.

Minority Stake and Mezzanine Option: BNP Paribas Fortis Private Equity takes minority positions with tickets from €1 million to €50 million, making it the natural first call for Belgian founders seeking growth capital while retaining majority ownership. Its investment in Leuven biotech AstriVax, totalling €30 million, demonstrates sector range.

Buy-and-Build Specialist: Vectis Private Equity manages a €125 million fund dedicated to acquiring and consolidating Belgian SMEs through a buy-and-build approach, making it one of the few domestic funds with an explicit roll-up investment thesis.

Top Belgian PE Firms in Detail

Cobepa

The defining characteristic of Cobepa's investment model is time: the Brussels-based firm operates without a fixed fund lifecycle, taking a genuinely long-term view on the companies it backs. With €4.4 billion in assets under management and 93 completed transactions since 2004, Cobepa has accumulated a track record that few Belgian peers can match. Its 45-person team currently oversees 20 active portfolio companies spanning business services, healthcare, and engineering consulting. The 2023 sale of Scalian, a top-10 engineering consulting firm in France, to Wendel illustrates the firm's ability to originate, scale, and exit cross-border investments at scale. Cobepa suits mid-to-large business owners and management teams who value continuity over speed, as well as institutional limited partners seeking long-duration private equity exposure.

GIMV

GIMV built its competitive edge through structure rather than scale. The Antwerp firm organises its €2.3 billion portfolio across five discrete sector platforms (Consumer, Healthcare, Life Sciences, Smart Industries, and Sustainable Cities), each staffed by dedicated investment professionals with deep sector expertise. This model, rare among Belgian PE investors, enables GIMV to provide operational and network support that a generalist fund cannot replicate. With more than 40 years of operating history, 244 total portfolio companies, and 62 current investments, the firm has the most extensive deal database of any Belgian-headquartered PE investor. Healthcare founders and life sciences entrepreneurs targeting an institutional exit have no better-aligned domestic option than GIMV's dedicated sector platforms.

GBL (Groupe Bruxelles Lambert)

GBL occupies a unique position in Belgian PE: the Brussels holding company manages €14 billion in net asset value across a portfolio that spans listed equities and private assets, giving it exposure beyond the SME focus of most domestic competitors. Publicly traded portfolio positions in adidas, Pernod Ricard, and SGS sit alongside private equity holdings in businesses including Affidea (pan-European diagnostic imaging), Canyon (direct-to-consumer cycling), and Parques Reunidos (leisure parks). This dual mandate makes GBL less accessible to founders than typical PE investors, but highly relevant to institutional limited partners seeking large-cap, long-duration Belgian capital exposure. The firm's permanent capital structure means it operates without the 10-year fund horizons that govern most European buyout funds.

Core Equity Holdings

Core Equity Holdings focuses on acquiring and building European platform companies with a long investment horizon, holding €2 billion in gross assets from its Brussels base. The firm prioritises platform creation over quick exits, identifying sectors where a well-capitalised platform company can consolidate fragmented markets through multiple add-on acquisitions. This approach places Core Equity in the space between traditional buyout and permanent capital, targeting businesses with the structural characteristics to support multiple bolt-on acquisitions over time. The firm is most relevant to management teams seeking a PE partner willing to invest across several acquisition cycles rather than targeting a single exit within a compressed timeframe.

Sofindev

Sofindev's investment thesis centres on Belgian and Benelux SMEs with strong fundamentals across diverse industries, including the energy transition, advanced manufacturing, and mobility. Based in Diegem, the firm concluded its Sofindev IV fund in 2024 and manages approximately $676 million in assets across current and historical investments. Portfolio companies include Altenova, Delta Engineering, Dynamate, Euphoria Mobility, and Polysto, reflecting the firm's willingness to back businesses across the industrial and services spectrum. Sofindev operates across both growth equity and buyout structures, giving it flexibility that purely buyout-oriented peers lack. Business owners in Flanders or the broader Benelux region planning succession or European expansion can leverage Sofindev's regional network and sector relationships.

Finco

Finco commands a niche that no other Belgian PE firm has matched: exclusive focus on companies operating in banking, insurance, asset management, and fintech. The Antwerp firm manages $180 million in assets and has built a portfolio that includes Ideal Systems, Datashift, and Whyte Corporate Affairs, demonstrating a consistent appetite for financial services businesses at the intersection of technology and compliance. The Plouvier family serves as reference shareholder, providing Finco with a stable capital base that supports patient investment decisions. Financial services founders and scale-ups navigating regulatory complexity benefit from Finco's sector-specific due diligence. Its post-investment support is significantly more targeted than the generalist approach of larger Belgian funds.

BNP Paribas Fortis Private Equity

BNP Paribas Fortis Private Equity offers Belgian founders a route to institutional PE capital without surrendering majority control. The Brussels-based arm of BNP Paribas Fortis invests €1 million to €50 million per transaction as a minority shareholder or mezzanine provider across all Belgian sectors except real estate, positioning itself as the preferred partner for entrepreneurs who want growth capital on founder-friendly terms. Its investment in AstriVax, a Leuven biotech, at €30 million in startup capital, alongside earlier backing for Point Chaud and Stûv, demonstrates genuine sector range. The bank's balance sheet backing removes the fund lifecycle pressure that affects closed-end PE vehicles, making it structurally better suited to companies seeking a patient minority investor.

Vectis Private Equity

Vectis Private Equity operates at the smaller end of the Belgian market with a €125 million fund and a concentrated mandate: Belgian SMEs targeted for growth capital and buy-and-build consolidation. Headquartered in Aalter, the firm applies a platform acquisition model, using an initial company purchase as the foundation for a series of bolt-on acquisitions that build sector density over time. This buy-and-build investment thesis makes Vectis particularly relevant to founders in fragmented service sectors where market share can be systematically accumulated. With 12 total portfolio companies and 10 transactions in the past five years per deal database records, the firm maintains an active pace for a fund of its size.

Vendis Capital

Vendis Capital takes a pan-European lens to Belgian PE, specialising in consumer goods SMEs with the brand equity and distribution foundations to expand across European markets. Headquartered in Diegem, the firm has built 30 portfolio company relationships since its 2009 founding, executing both buyouts and growth equity transactions across Belgium and broader Europe. Its consumer sector focus is one of the most specific of any Belgian-headquartered fund, making Vendis the natural first approach for founders of premium consumer brands, specialty food and beverage businesses, or branded consumer services seeking institutional backing for European expansion. The firm does not publish AUM figures, but its deal activity across 19 transactions in recent years signals consistent capital deployment.

Integra

Integra offers Belgian limited partners a dual-access model that is uncommon in the domestic market: it combines direct investments in Belgian SMEs with co-investments in international companies alongside the global PE funds it invests in as a fund-of-funds manager. Based in Ghent and managing more than €250 million after expanding its fund from €175 million in 2023, Integra provides LP access to international PE returns alongside Belgian market exposure in a single vehicle. The portfolio spans technology, manufacturing, services, and consumer goods. For Belgian institutional investors or family offices building diversified private equity allocations, Integra eliminates the complexity of managing relationships with both domestic and international fund managers separately.

Investment Trends and Capital Flows

ESG and Sustainable Investing

ESG criteria have moved from optional to structural across Belgian PE, reflecting AIFMD obligations and EU-level ESG disclosure rules. Capital is flowing toward green technology, renewable energy, and sustainable agriculture at a pace that reflects both regulatory pressure and genuine LP demand. GIMV's dedicated Sustainable Cities platform represents one of the clearest institutional commitments to this theme by a Belgian PE investor.

Digitalization and Technology-Enabled Growth

Belgian PE firms increasingly use digitalization as the primary value-creation lever in portfolio companies, backing digital services, SaaS businesses, and technology-enabled professional services. Finco's investments in Datashift, a data consultancy, and Ideal Systems, a software provider for contact centres, illustrate how even sector-specialist funds prioritise technology exposure to drive earnings before interest, taxes, depreciation, and amortization (EBITDA) growth within their portfolios.

Healthcare, Biotech, and Life Sciences

Healthcare and life sciences investment is growing faster than the Belgian PE market average, supported by GIMV's dedicated Healthcare and Life Sciences platforms and by bank-affiliated PE arms willing to fund early-stage biotech. BNP Paribas Fortis PE's €30 million commitment to AstriVax, a Leuven-based vaccine biotech, signals institutional appetite for earlier-stage life sciences than traditional buyout funds would typically accept.

Buy-and-Build and Platform Consolidation

Platform creation through sequential bolt-on acquisitions has become a dominant strategy among Belgian mid-market investors. Vectis, Sofindev, and Core Equity Holdings all execute versions of this approach, targeting fragmented Belgian SME sectors where a well-capitalised platform company can achieve market leadership through consolidation. Buy-and-build activity generates its own deal flow as acquired businesses expand, creating compounding returns for firms skilled at post-acquisition integration.

Cross-Border European Expansion

Belgian PE firms operate far beyond their domestic borders, with Cobepa's sale of the French engineering firm Scalian to Wendel in 2023 being the most prominent recent example of cross-border exit activity. Sofindev invests across the broader Benelux region, while international fund managers including General Atlantic and Warburg Pincus continue to direct uncommitted capital into Belgian mid-market targets. Belgium's position between Amsterdam, Paris, and Frankfurt makes it structurally attractive for pan-European platform strategies.

How to Evaluate PE Investors in This Market

Fund size alignment is the most commonly mishandled factor in PE firm selection. A business seeking €5 million in growth capital should not approach Cobepa, which targets larger platform transactions. The right starting point is BNP Paribas Fortis PE or Vectis, both of which operate in the €1 million to €50 million ticket range. Misalignment wastes time on both sides and signals a lack of market knowledge to the firm's investment team.

Sector expertise deserves verification, not assumption. A firm that lists healthcare among its sectors may have completed one transaction in medical devices a decade ago while concentrating 90% of its activity in industrials. Check actual portfolio company lists against your industry vertical, and look for firms with dedicated sector platforms or named healthcare or technology partners on their investment teams.

The distinction between patient capital and closed-end fund structures has practical consequences for founders. Cobepa and GBL operate without fixed fund lifecycles, which means exit timing can reflect business fundamentals rather than fund maturity. Most other Belgian PE firms operate on 10-year closed-end structures, creating a defined exit window of 4–7 years post-investment. Founders should understand which model they are entering before signing a term sheet.

Value-add beyond capital separates the best Belgian PE partners from passive capital providers. Evaluate whether a firm offers operational support, cross-border network introductions, or sector-specific procurement advantages. A general partner (GP) who cannot articulate a specific value-creation plan beyond capital injection is unlikely to accelerate your business meaningfully. The Private Capital Belgium member directory and annual Belgian PE industry rankings are the most reliable starting points for identifying active, transparent investors and understanding their market positioning.

Which Firm Fits Your Needs?

Founders seeking growth capital while maintaining a majority stake should focus on BNP Paribas Fortis Private Equity, which invests up to €50 million as a minority shareholder, or Vectis Private Equity for businesses suited to a buy-and-build consolidation strategy. Both firms are structured to preserve founder ownership and operational autonomy. Healthcare and life sciences businesses specifically should approach GIMV, which operates dedicated investment platforms in both verticals and has the sector depth to add post-investment value beyond capital. Fintech and financial services founders face an even clearer choice: Finco is the sole Belgian PE investor with exclusive focus on banking, insurance, and fintech, and its two decades of sector-specific deal experience represent a significant advantage over generalist alternatives.

Business owners planning succession or a full exit will find Sofindev, KeBeK Private Equity, and Down 2 Earth Capital among the most active buyers of established Belgian SMEs. All three execute buyout and growth equity transactions across diverse industries, with Sofindev offering the strongest track record among the three given its recently concluded fourth fund. Consumer goods businesses with European expansion ambitions are best served by Vendis Capital, whose pan-European distribution expertise is embedded in its investment model.

For limited partners (LPs) building or expanding Belgian private market allocations, Integra's fund-of-funds plus co-investment model provides diversified access to both domestic SME deals and international PE funds within a single vehicle. LPs seeking larger-scale, long-duration exposure to Belgian capital markets will find GBL the most natural choice: its €14 billion NAV, diversified across listed and private assets, represents the broadest expression of Belgian long-term capital available to institutional investors.

Methodology

This article was compiled using data from Private Capital Belgium (formerly BVA), a PE deal database tracking 17 verified Belgian investors with confirmed deal histories, 2024 Belgian PE industry rankings, and Belgian private equity market analysis covering 2021–2025. Firm AUM figures are drawn directly from deal databases, firm-level disclosures, and industry publications; where no verified figure was available, AUM has been omitted rather than estimated. Editorial picks reflect strategy differentiation, deal evidence, and verifiable fund data rather than commercial relationships.

Firms were selected for inclusion based on active deal history in Belgium, verifiable portfolio data, and headquarters or primary operations within the country. The private equity Belgium market size figure of €25.7 billion excludes venture capital per the industry definition used as the primary market sizing source. Data reflects conditions primarily from 2021 through early 2025; fund raises and notable transactions are referenced through the 2024 Sofindev IV close and the 2023 Cobepa-Scalian exit.